Lamotrigine therapeutic thresholds

Seizure

Volumn 17, Issue 5, 2008, Pages 391-395

  Søndergaard Khinchi, Marianne ^a   Nielsen, Kirsten Annette ^a   Dahl, Marit ^a   Wolf, Peter ^a  

^a DANISH EPILEPSY CENTRE   (Denmark)

Author keywords

Lamotrigine monotherapy; Therapeutic drug monitoring; Therapeutic threshold

Indexed keywords

LAMOTRIGINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG DOSE TITRATION; DRUG MONITORING; DRUG TOLERABILITY; EPILEPSY; HUMAN; MONOTHERAPY; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

ADOLESCENT; ADULT; AGED; ANTICONVULSANTS; CHILD; CHILD, PRESCHOOL; DENMARK; DISEASE-FREE SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION; EPILEPSY; FEMALE; HUMANS; MALE; MIDDLE AGED; OUTPATIENTS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; TRIAZINES;

EID: 42049113377     PISSN: 10591311     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.seizure.2007.11.023     Document Type: Article

References (19)

1. Kilpatrick E.S., Forrest G., and Brodie M.J. Concentration-effect and concentration-toxicity relationships with lamotrigine: a prospective study. Epilepsia 37 (1996) 534-538
2. Bartoli A., Guerrini R., Belmonte A., Alessandri M.G., Gatti G., and Perucca E. The influence of dosage, age, and comedication on steady state plasma lamotrigine concentrations in epileptic children: a prospective study with preliminary assessment of correlations with clinical response. Therap Drug Monit 19 (1997) 252-260
3. Chong E., and Dupuis L.L. Therapeutic drug monitoring of lamotrigine. Ann Pharmacother 36 (2002) 917-920
4. Perucca E. Is there a role for therapeutic monitoring of new anticonvulsants?. Clin Pharmacokinet 38 (2000) 191-204
5. Johannessen S.I., and Tomson T. Pharmacokinetic variability of newer antiepileptic drugs: when is monitoring needed?. Clin Pharmacokinet 45 (2006) 1061-1075
6. Morris R.G., Black A.B., Harris A.L., Batty A.B., and Sallustio B.C. Lamotrigine and therapeutic drug monitoring: retrospective survey following the introduction of a routine service. Br J Clin Pharmacol 46 (1998) 547-551
7. Fröscher W., Keller F., Vogt H., and Krämer G. Prospective study on concentration-efficacy and concentration-toxicity: correlations with lamotrigine serum levels. Epileptic Disord 4 (2002) 49-56
8. Johannessen S.I., Battino D., Berry D.J., Bialer M., Krämer G., Tomson T., et al. Therapeutic drug monitoring of the newer antiepileptic drugs. Therap Drug Monit 25 (2003) 347-363
9. Johannessen S.I. Can pharmacokinetic variability be controlled for the patient's benefit? The place of TDM for new AEDs. Therap Drug Monit 27 (2005) 710-713
10. Richens A., and Dunlop A. Serum Phenytoin levels in the management of epilepsy. Lancet 2 (1975) 247.48
11. Hirsch L.J., Weintraub D., Buchsbaum R., Spencer H.T., Hager M., Strake T., et al. Correlating LTG serum concentration with tolerability in patients with epilepsy. Neurology 63 (2004) 1022-1026
12. Sabers A., Buchholt J.M., Uldall P., and Hansen E.L. Lamotrigine plasma levels reduced by oral contraceptives. Epilepsy Res 47 (2001) 151-154
13. Sabers A., Ohman I., Christensen J., and Tomson T. Oral contraceptives reduce lamotrigine plasma levels. Neurology 61 (2003) 570-571
14. Petrenaite V., Sabers A., and Hansen-Schwartz J. Individual changes in lamotrigine plasma concentrations during pregnancy. Epilepsy Res 65 (2005) 185-188
15. Adab N. Therapeutic monitoring of antiepileptic drugs during pregnancy and in the postpartum period: is it useful?. CNS Drugs 20 (2006) 791-800
16. Morris R.G., Lee M.Y.Y., Cleanthous X., and Black A.B. Long-term follow-up using a higher target range for lamotrigine monitoring. Therap Drug Monit 26 (2004) 626-632
17. Croci D., Salmaggi A., de Grazia U., and Bernardi G. New high-performance liquid chromatographic method for plasma/serum analysis of lamotrigine. Therap Drug Monit 23 (2001) 665-668
18. Wolf P., Pastuchova T., and Mataringa M. Decline of seizure propensity in seizure free patients as reflected in the evolution of the therapeutic antiepileptic drug threshold. Epilepsy Behav 8 (2006) 384-390
19. Engel Jr. J. Introduction to temporal lobe epilepsy. Epilepsy Res 26 (1996) 141-150